Wednesday, April 04, 2012
Cancer Science - Wrong 47 out of 53 Times
While science can and has informed us of many things which we did not fully understand over the years, it is best that we retain a healthy skepticism of its claims until they are completely verified, whether the science be environmental, or biological.
A former researcher at Amgen Inc has found that many basic studies on cancer—a high proportion of them from university labs—are unreliable, with grim consequences for producing new medicines in the future.
During a decade as head of global cancer research at Amgen, C. Glenn Begley identified 53 “landmark” publications—papers in top journals, from reputable labs—for his team to reproduce. Begley sought to double-check the findings before trying to build on them for drug development.
Result: 47 of the 53 could not be replicated. He described his findings in a commentary piece published on Wednesday in the journal Nature.
Via Clayton Cramer.
The Fix Is In On Ford
An article put up at The Daily Ticker, headlined Ford Posts Best March Sales in 5 Years: Here’s How Ford Averted Bankruptcy in 2008, touts Ford Motor Company’s seemingly singular success in not requiring government intervention in order to remain a viable company. The article informs readers that Ford was so intent on remaining free of government bailout intervention that their financial belt tightening included measures so constricting that,
“They got to the point where they stopped paying to water the plants inside their buildings [and] stopped paying to wash the windows in order to save money.”
That’s some sacrifice.
While I am pleased that Ford is on the track to profitability, and was not a participant in the government bailout of the auto industry, Ford’s success is not as government free as The Daily Ticker and Ford would lead you to believe, as I pointed out in June 2009, when I linked to a Wall Street Journal article headlined as follows.
The fix is in at Ford, but the fix was not free of big brother’s muscle.